4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-031189
President & CEO sold 13,383 shares at $31.37 ($419,825)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-05-16 | Sale | −13,383 | $31.37 | $419,825 | 295,326 | D: show line 1 in the form |
| Open-market sales · 13,383 sh · avg $31.37 · $419,825 | |||||||
Loading xslF345X03/doc4.xml…